News

Filter

Current filters:

AbbVieOncology

1 to 9 of 13 results

ASH 2014: AbbVie's venetoclax shows promise in Phase II trial

ASH 2014: AbbVie's venetoclax shows promise in Phase II trial

08-12-2014

US drugmaker AbbVie presented data at the American Society of Hematology’s annual meeting, demonstrating…

AbbVieOncologyPharmaceuticalResearchUSA

AbbVie links with Calico in up to $1.5 billion effort on drug discovery

AbbVie links with Calico in up to $1.5 billion effort on drug discovery

04-09-2014

US pharma company AbbVie has entered a novel R&D collaboration with recently-formed Calico, intended…

AbbVieBiotechnologycalicoNeurologicalOncologyResearch

Infinity and AbbVie collaborate on duvelisib in deal worth up to $805 million

Infinity and AbbVie collaborate on duvelisib in deal worth up to $805 million

03-09-2014

US drug discovery firm Infinity Pharmaceuticals has entered into a global collaboration with AbbVie to…

AbbVieduvelisibInfinity PharmaceuticalsIPI-145LicensingOncologyPharmaceutical

US and European orphan status for AbbVie’s glioblastoma candidate

US and European orphan status for AbbVie’s glioblastoma candidate

04-08-2014

Both the European Medicines Agency and the US Food and Drug Administration have granted orphan drug designation…

AbbVieABT-414Brain tumorEuropeGlioblastoma multiformeMarkets & MarketingOncologyPharmaceuticalRare diseasesRegulationUS Food and Drug AdministrationUSA

Breakthrough designation for B-MS/AbbVie’s MM drug elotuzumab

19-05-2014

The US Food and Drug Administration has granted elotuzumab, an investigational humanized monoclonal antibody…

AbbVieBristol-Myers SquibbelotuzumabOncologyPharmaceuticalRegulationUSA

AbbVie to spend $320 million to establish Singapore manufacturing presence

AbbVie to spend $320 million to establish Singapore manufacturing presence

06-02-2014

US drugmaker AbbVie says it plans to invest $320 million to establish operations in Singapore for small…

AbbVieAsia-PacificImmunologicalsOncologyPharmaceuticalProduction

Seattle Genetics expands cancer drug collaboration with AbbVie

Seattle Genetics expands cancer drug collaboration with AbbVie

09-01-2014

US biotech firm Seattle Genetics says it has further expanded its antibody-drug conjugate (ADC) collaboration…

AbbVieBiotechnologyLicensingOncologySeattle Genetics

1 to 9 of 13 results

COMPANY SPOTLIGHT

Menarini

Back to top